Pfizer begins late-stage testing of Spark's hemophilia B gene therapy By: Philadelphia Business Journal via Business Journals July 16, 2018 at 16:16 PM EDT The two companies, which said a licensing deal in 2014, have completed the transfer of the therapy's development from Spark to Pfizer. Read More >>
